2,6-Dipropyl-5,6-dihydro-2H-thiopyran-3-carbaldehyde
Common Name: |
2,6-Dipropyl-5,6-dihydro-2H-thiopyran-3-carbaldehyde |
IUPAC Name: |
2,6-dipropyl-3,6-dihydro-2H-thiopyran-5-carbaldehyde |
Molecular Formula: |
C12H20OS |
SMILES: |
CCCC1CC=C(C(S1)CCC)C=O |
Inchi: |
1S/C12H20OS/c1-3-5-11-8-7-10(9-13)12(14-11)6-4-2/h7,9,11-12H,3-6,8H2,1-2H3 |
Inchi Key: |
QCIOSRSNVYPUHS-UHFFFAOYSA-N |
Cas No: |
61407-00-9 |
Aldehydes |
Pyran |
S-compounds |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
212.35 |
Mass (g/mol) |
212.123 |
Molar Refractivity |
65.00 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
5 |
Rings |
1 |
TPSA |
42.37 |
Hetero Atoms |
2 |
Heavy Atoms |
14 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
|
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.75 |
LogP |
3.586 |
iLOGP |
2.80 |
XLOGP3 |
3.35 |
WLOGP |
3.59 |
MLOGP |
2.77 |
ESOL Log S |
-2.94 |
ESOL Solubility (mg/ml) |
0.245 |
ESOL Solubility (mol/l) |
0.001 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.92 |
Ali Solubility (mg/ml) |
0.03 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.02 |
Silicos-IT Solubility (mg/ml) |
0.2 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.22 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.852 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.3 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
1 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |